SMARCA2 and non-small cell lung carcinoma: To further assess whether SMARCA2-negative expression was an independent predictor of OS and PFS in NSCLC, we then performed a multivariate analysis using the Cox proportional risk regression model, and all variables with p < 0.05 in the univariate analysis were included in the multivariate analysis.